E-LIB Suche - Ergebnisse für: O'Gorman, C.

1

Efficacy of esmethadone in patients with major depressive d..:

Fava, M. ; Stahl, S.M. ; Pani, L....
Neuroscience Applied. 2 (2023) - p. 102964 , 2023

Link: https://doi.org/10.1016/..

2

101P Progression-free survival is an acceptable surrogate e..:

Yarza, R. ; Kountouri, M. ; Costa Guedes, H.M....
Immuno-Oncology and Technology. 20 (2023) - p. 100573 , 2023

Link: https://doi.org/10.1016/..

3

No indication of abuse potential and absence of withdrawal ..:

Shram, M. ; Pappagallo, M. ; Henningfield, J....
Neuroscience Applied. 2 (2023) - p. 102965 , 2023

Link: https://doi.org/10.1016/..

4

Prognostic Significance of Circulating Tumour Cells and Dis..:

Ward, M. ; Lewis, F. ; O'Gorman, C....
The Journal of Liquid Biopsy. 1 (2023) - p. 100062 , 2023

Link: https://doi.org/10.1016/..

5

PMH40 Effects of AXS-05 on Patient Reported Depressive Symp..:

O'Gorman, C. ; Feliz, S. ; Jones, A....
Value in Health. 24 (2021) - p. S135 , 2021

Link: https://doi.org/10.1016/..

6

PMH42 Early Improvements in Functioning and Quality of Life..:

Jones, A. ; Feliz, S. ; O'Gorman, C....
Value in Health. 24 (2021) - p. S135 , 2021

Link: https://doi.org/10.1016/..

7

0739 Efficacy and Safety of AXS-12 in the Treatment of Narc..:

Tabuteau, H ; Thorpy, M J ; Jones, A.
Sleep. 43 (2020) Supplement_1 - p. A281-A281 , 2020

Link: https://doi.org/10.1093/..

8

P.327 Efficacy and safety of AXS-05, an oral, NMDA receptor..:

O'gorman, C. ; Jones, A. ; Iosifescu, D..
European Neuropsychopharmacology. 40 (2020) - p. S190 , 2020

Link: https://doi.org/10.1016/..

9

A FRAMEWORK FOR DEVELOPING PHARMACOTHERAPY FOR AGITATION IN..:

O'Gorman, C. ; Khoury, R. ; Anderson, A....
The Journal of Prevention of Alzheimer's Disease. , 2020

Link: https://doi.org/10.14283..

10

Evaluation of the proposed anti‐N‐methyl‐d‐aspartate recept..:

Warren, N. ; O'Gorman, C. ; Blum, S....
Acta Psychiatrica Scandinavica. 142 (2020) 1 - p. 52-57 , 2020

Link: https://doi.org/10.1111/..

11

AXS-05 (Dextromethorphan/Bupropion): psychopharmacology and..:

O'Gorman, C. ; Jones, A. ; Tabuteau, H.
European Neuropsychopharmacology. 29 (2019) - p. S458 , 2019

Link: https://doi.org/10.1016/..

12

Elucidation of factors responsible for formation of white f..:

Schmidmeier, C. ; O'Gorman, C. ; Drapala, K.P...
Colloids and Surfaces A: Physicochemical and Engineering Aspects. 575 (2019) - p. 245-255 , 2019

Link: https://doi.org/10.1016/..

13

P.601 AXS-05 (dextromethorphan/bupropion), a novel, oral, i..:

O'gorman, C. ; Anderson, A. ; Jacobson, M...
European Neuropsychopharmacology. 29 (2019) - p. S410 , 2019

Link: https://doi.org/10.1016/..

14

Effect of exercise modality on markers of insulin sensitivi..:

Cremona, A. ; O'Gorman, C. ; Cotter, A...
Obesity Science & Practice. 4 (2018) 5 - p. 455-467 , 2018

Link: https://doi.org/10.1002/..

15

Refining the psychiatric syndrome of anti‐N‐methyl‐d‐aspart..:

Warren, N. ; Siskind, D. ; O'Gorman, C.
Acta Psychiatrica Scandinavica. 138 (2018) 5 - p. 401-408 , 2018

Link: https://doi.org/10.1111/..